Nembutal Pentobarbital (Capsules, powder and pills)

Price range: $259.00 through $1,000.00

Nembutal (pentobarbital sodium) is a short-acting barbiturate and central nervous system depressant. It is a Schedule II/Class B controlled substance with legitimate medical uses including emergency control of seizures (status epilepticus), sedation, and as a preanesthetic agent. Pentobarbital is also the primary agent used for veterinary euthanasia and, in regulated contexts, for physician-assisted dying (where legally permitted).

Quantity (Pills)

Quantity (Liquid)

Quantity Powder Form)

Clear

Description
Additional information

What is Nembutal (Pentobarbital)?

Pentobarbital is a short-acting barbiturate, a class of drugs that depress the central nervous system (CNS). Barbiturates were once widely prescribed as sleeping pills and sedatives but have largely been replaced by safer drugs (benzodiazepines) due to their high potential for overdose, dependence, and fatal withdrawal .

Brand Name: Nembutal (pentobarbital sodium)
Chemical Name: Sodium 5-ethyl-5-(1-methylbutyl) barbiturate
CAS Registry Number: 57-33-0
DEA Schedule: Schedule II (US) / Class B (UK)

Mechanism of Action:

Pentobarbital binds to GABA-A receptors in the brain, increasing the duration that chloride ion channels remain open. This potentiates the inhibitory effects of GABA, resulting in CNS depression ranging from mild sedation to hypnosis, deep coma, and at high doses, death from respiratory and circulatory collapse .

Legitimate Medical Uses:

Use	Description
Status Epilepticus	Emergency control of prolonged seizures refractory to benzodiazepines and other anticonvulsants
Sedation	Preanesthetic sedation (though less common today due to unpredictable response)
Insomnia (short-term)	Hypnotic for sleep induction; limited to <2 weeks due to tolerance
Elevated Intracranial Pressure (off-label)	High doses used in refractory head trauma cases

Available Formulations:

Formulation	Concentration	Use
Injectable solution (human)	50 mg/mL	IV/IM administration for seizures/sedation
Veterinary euthanasia solution (alone)	390 mg/mL (6 grains/mL)	Animal euthanasia
Veterinary combination	390 mg/mL + 50 mg/mL phenytoin	Animal euthanasia (hastens cardiac arrest)

Dosage Information (Educational):

Indication	Adult Dose	Route
Seizures (status epilepticus)	5-15 mg/kg initial, then 0.5-5 mg/kg/hour infusion	IV
Insomnia	150-200 mg (IM) or 100-200 mg (IV)	IM/IV
Sedation (preanesthetic)	100 mg initial (70 kg adult)	IV
Veterinary euthanasia (dogs)	1 mL per 10 lb body weight (390 mg/mL solution)	IV/Intracardiac

Contraindications:

Known hypersensitivity to barbiturates
History of manifest or latent porphyria (barbiturates can trigger acute attacks)
Severe respiratory insufficiency
Marked hepatic impairment
Pregnancy (may cause fetal harm)

Warnings and Precautions:

Tolerance and Dependence: Prolonged use leads to physical and psychological dependence. Abrupt withdrawal can cause delirium, seizures, and death .
Respiratory Depression: IV administration must not exceed 50 mg/minute. Equipment for resuscitation must be available .
Suicide Risk: Prescribe with caution in mentally depressed or suicidal patients .
Pediatric Neurotoxicity: Repeated or prolonged use in children <3 years may adversely affect neurodevelopment .
Fetal Harm: May cause fetal abnormalities; withdrawal symptoms in neonates exposed in utero .

Side Effects:

Common	Serious
Drowsiness, sedation	Respiratory depression
Dizziness, lightheadedness	Hypotension (with rapid IV)
Nausea, vomiting	Laryngospasm
Headache	Paradoxical excitement (in pain patients)
Hangover effect (next-day grogginess)	Physical dependence, withdrawal seizures
	Hepatic dysfunction (with prolonged use)

Tolerance and Withdrawal:

Barbiturates lose effectiveness for sleep induction and maintenance after approximately 2 weeks of regular use . Withdrawal from pentobarbital after physical dependence develops can be life-threatening, characterized by:

Seizures (grand mal)
Delirium
Hallucinations
Anxiety, tremors, insomnia
Cardiovascular collapse (severe cases)

Overdose and Toxicity:

Parameter	Information
Lethal dose (oral)	Approximately 3,000 mg (30 × 100 mg tablets)
Lethal dose for assisted dying (oral)	10,000-15,000 mg (10-15 grams)
Onset of unconsciousness (oral 15g)	~3 minutes
Time to death (oral 15g)	~20-30 minutes (respiratory arrest)
Time to death (IV, high dose)	~1 minute

Overdose Signs:

Respiratory depression → apnea
Hypotension, circulatory collapse
Coma
Cardiac arrest due to anoxia

Overdose Management:

Airway support and mechanical ventilation
IV fluids and vasopressors for hypotension
Activated charcoal (if recent oral ingestion)
No specific antidote; supportive care only

Legal Status:

Jurisdiction	Schedule	Notes
United States (federal)	Schedule II	High potential for abuse
Virginia (example state)	Schedule III	Some formulations or combinations may be Schedule III
United Kingdom	Class B	Controlled drug
Canada	Schedule I	Controlled substance
Oregon (physician-assisted dying)	Legal for assisted dying	Under Death with Dignity Act (prescribed for terminally ill)

Veterinary Use (Euthanasia):

Pentobarbital is the standard agent for humane euthanasia of animals. Veterinary euthanasia solutions contain high concentrations (390 mg/mL or 6 grains/mL) and are often combined with phenytoin to hasten cardiac arrest. These solutions are never for human use and contain dyes (rhodamine B or green dye) to distinguish them from therapeutic drugs .

Human Warning for Veterinary Products:

HUMAN WARNING: Caution should be exercised to avoid contact of the drug with open wounds or accidental self-inflicted injections. Keep out of reach of children. If eye contact, flush with water and seek medical advice/attention .

Physician-Assisted Dying (Context):

In jurisdictions where assisted dying is legal (e.g., Oregon, Washington, Switzerland), pentobarbital or secobarbital are the agents used. The standard oral dose is 10-15 grams (100-150 times a therapeutic hypnotic dose), typically taken with an antiemetic (metoclopramide) 1 hour prior to prevent vomiting .

Time Course of Assisted Dying (Oral 15g):

Unconsciousness: ~3 minutes
Breathing stops: ~20 minutes
Cardiac arrest: ~30 minutes

With intravenous administration (Swiss model):

Unconsciousness: seconds
Death: ~1 minute

Drug Interactions:

Drug Class	Interaction	Effect
Alcohol, benzodiazepines, opioids	Additive CNS depression	Increased sedation, respiratory depression, death
Oral contraceptives	Decreased efficacy (CYP enzyme induction)	Increased risk of breakthrough bleeding/pregnancy
MAO inhibitors	Prolonged barbiturate effect	Potential toxicity
Warfarin, anticonvulsants	Increased metabolism	Decreased efficacy of other drugs

Pregnancy and Lactation:

Pregnancy: May cause fetal harm; neonatal withdrawal syndrome (seizures, hyperirritability) can occur up to 14 days after birth .
Breastfeeding: Distributed into human milk; use with caution .

Storage and Disposal:

Store in secure, locked cabinet out of reach of children
For unused pentobarbital (e.g., from assisted dying prescriptions): Do not flush (unlike some opioids). Mix with coffee grounds or cat litter and dispose in household trash, or use drug take-back program .

Key Educational Message:

Pentobarbital is a powerful CNS depressant with legitimate but limited medical uses (status epilepticus, refractory seizures). Its high potential for tolerance, dependence, and fatal overdose led to its replacement by benzodiazepines for most indications. Veterinary euthanasia solutions are highly concentrated and never for human use. In regulated assisted-dying contexts, pentobarbital produces rapid, painless death when administered at lethal doses.